中國澱粉(03838.HK)料首5月實現純利約9500萬元
格隆匯 6 月 17日丨中國澱粉(03838.HK)發佈公告,根據集團截至2020年5月31日止五個月未經審核綜合管理賬目的初步審閲,集團預期錄得純利約人民幣9500萬元,較2019年同期純利增加約252%。
董事會認為,集團於該期間的純利較2019年同期大幅增加主要由於以下因素:(i)集團的玉米澱粉及賴氨酸生產總銷量增加乃由於壽光金玉米生物科技有限公司(公司的間接非全資附屬公司)分別於2019年4月及今年3月開始生產及銷售玉米澱粉及賴氨酸所致。(ii)集團透過採用先進生產方法、加強生產監控及提升產量,從而降低其銷售單位成本。(iii)集團部分產品(如玉米胚芽、玉米蛋白粉及玉米糠麩)於該期間的售價升幅足以補償集團採購玉米粒的原料成本升幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.